🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
A randomized, open-label, 3-period crossover study....
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-25
Trial ID
NCT01319006
Treatments Being Tested
Daprodustat has demonstrated an ability to effectively raise hemoglobin con...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-01-10
Trial ID
NCT03446612
GSK1278863 is an orally available, hypoxia-inducible factor - prolyl hydrox...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-02-17
Trial ID
NCT02689206
Treatments Being Tested
The purpose of this multi-center study is to evaluate the efficacy and safe...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-11
Trial ID
NCT03029208
Treatments Being Tested
Daprodustat administration has the potential, by virtue of increasing hypox...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-30
Trial ID
NCT03457701
Absorption, metabolism and excretion of daprodustat (GSK1278863) have been ...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-10-10
Trial ID
NCT03239522
The purpose of this multi-center study in non-dialysis participants with an...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-03-05
Trial ID
NCT03409107
Treatments Being Tested
This study is intended to evaluate the dose-response relationship of GSK127...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-01
Trial ID
NCT01977482
Treatments Being Tested
As per non-clinical studies, prolyl hydroxylase inhibitor GSK1278863 can pr...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-15
Trial ID
NCT02231190
Treatments Being Tested